Clinical Trial Update: Autologous Bone Marrow Mononuclear Cell Implantation for Moderate to Severe Peripheral Arterial Disease [NA]

View source ↗

Summary

This clinical trial update reports on autologous bone marrow mononuclear cell implantation as a treatment for moderate to severe peripheral arterial disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Arterial Disease

Drugs mentioned

• Autologous bone marrow mononuclear cell implantation

Snippet

Sponsor: The Vascular and Vein Center, Columbus, OH | Conditions: Peripheral Arterial Disease | NA | Status: COMPLETED